Financial support and resources available for businesses impacted by COVID-19.

Support for businesses impacted by COVID-19.

logo of Tekmira Pharmaceuticals Corporation
Exited company

Tekmira Pharmaceuticals Corporation

Details
Region
Prairies and West
Industry sector
Biotechnology
Investment year
2002
Fund
Healthcare Venture Fund
Learn More
About the company

Tekmira is a leader in the development of the therapeutic agents based upon Nobel prize-winning breakthroughs in the field of gene silencing, known as RNA interference (RNAi). Tekmira’s three lead RNAi product candidates target cholesterol management, cancer and Ebola infection.